• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

SARTORIUS STEDIM BIOTECH S.A.

Notes

No. Proposition For Against Abstain
1

APPROVAL OF THE ANNUAL FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 AND DISCHARGE TO THE DIRECTORS

2

APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2025

3

APPROPRIATION OF PROFIT FOR THE YEAR ENDED DECEMBER 31, 2025

4

APPROVAL OF THE REMUNERATION POLICY AND SETTING OF THE MAXIMUM AMOUNT OF THE TOTAL ANNUAL REMUNERATION TO BE ALLOCATED TO THE BOARD OF DIRECTORS FOR THE YEAR ENDED 31 DECEMBER 2026

5

APPROVAL OF THE INFORMATION REFERRED TO IN ARTICLE L. 22-10-9 OF THE FRENCH COMMERCIAL CODE RELATING TO THE REMUNERATION OF CORPORATE OFFICERS FOR THE FINANCIAL YEAR ENDED DECEMBER 31, 2025

6

APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL COMPONENTS OF THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID OR AWARDED TO "MR. JOACHIM KREUZBURG", CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE YEAR ENDED DECEMBER 31, 2025 FROM JANUARY 1, 2025 TO JUNE 30, 2025

7

APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL COMPONENTS OF THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID OR AWARDED TO "MR. MICHAEL GROSSE", CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE YEAR ENDED DECEMBER 31, 2025 FROM JULY 1, 2025 TO DECEMBER 31, 2025

8

APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL COMPONENTS OF THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID OR AWARDED TO THE CHIEF EXECUTIVE OFFICER FOR THE YEAR ENDED DECEMBER 31, 2025

9

APPROVAL OF THE REMUNERATION POLICY OF THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE YEAR ENDED DECEMBER 31, 2026

10

APPROVAL OF THE REMUNERATION POLICY OF THE CHIEF EXECUTIVE OFFICER FOR THE YEAR ENDED 31 DECEMBER 2026

11

RATIFICATION OF THE CO-OPTATION OF "MR MICHAEL GROSSE" AS DIRECTOR

12

AUTHORIZATION GIVEN TO THE BOARD OF DIRECTORS TO ALLOW THE COMPANY TO INTERVENE IN ITS OWN SHARES

13

AMENDMENT OF ARTICLE 17 OF THE COMPANY'S ARTICLES OF ASSOCIATION

14

DELEGATION OF AUTHORITY GRANTED TO THE BOARD OF DIRECTORS TO DECIDE ON THE ISSUANCE OF SHARES, WITH CANCELLATION OF SHAREHOLDERS' PREFERENTIAL SUBSCRIPTION RIGHTS, TO NAMED BENEFICIARIES

15

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS IN ORDER TO REDUCE THE SHARE CAPITAL IN ACCORDANCE WITH THE PROVISIONS OF ARTICLE L. 22-10-62 OF THE FRENCH COMMERCIAL CODE